These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


111 related items for PubMed ID: 12054761

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Discovery of a stable dimeric mutant of cyanovirin-N (CV-N) from a T7 phage-displayed CV-N mutant library.
    Han Z, Xiong C, Mori T, Boyd MR.
    Biochem Biophys Res Commun; 2002 Apr 12; 292(4):1036-43. PubMed ID: 11944919
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Analysis of sequence requirements for biological activity of cyanovirin-N, a potent HIV (human immunodeficiency virus)-inactivating protein.
    Mori T, Shoemaker RH, Gulakowski RJ, Krepps BL, McMahon JB, Gustafson KR, Pannell LK, Boyd MR.
    Biochem Biophys Res Commun; 1997 Sep 08; 238(1):218-22. PubMed ID: 9299482
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Flipping the switch from monomeric to dimeric CV-N has little effect on antiviral activity.
    Barrientos LG, Lasala F, Delgado R, Sanchez A, Gronenborn AM.
    Structure; 2004 Oct 08; 12(10):1799-807. PubMed ID: 15458629
    [Abstract] [Full Text] [Related]

  • 8. Identification and characterization of peptides that bind to cyanovirin-N, a potent human immunodeficiency virus-inactivating protein.
    Han Z, Simpson JT, Fivash MJ, Fisher R, Mori T.
    Peptides; 2004 Apr 08; 25(4):551-61. PubMed ID: 15165709
    [Abstract] [Full Text] [Related]

  • 9. Dissecting carbohydrate-Cyanovirin-N binding by structure-guided mutagenesis: functional implications for viral entry inhibition.
    Barrientos LG, Matei E, Lasala F, Delgado R, Gronenborn AM.
    Protein Eng Des Sel; 2006 Dec 08; 19(12):525-35. PubMed ID: 17012344
    [Abstract] [Full Text] [Related]

  • 10. Solution structure of cyanovirin-N, a potent HIV-inactivating protein.
    Bewley CA, Gustafson KR, Boyd MR, Covell DG, Bax A, Clore GM, Gronenborn AM.
    Nat Struct Biol; 1998 Jul 08; 5(7):571-8. PubMed ID: 9665171
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A recombinant allosteric lectin antagonist of HIV-1 envelope gp120 interactions.
    McFadden K, Cocklin S, Gopi H, Baxter S, Ajith S, Mahmood N, Shattock R, Chaiken I.
    Proteins; 2007 May 15; 67(3):617-29. PubMed ID: 17348010
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Thermodynamic effects of proline introduction on protein stability.
    Prajapati RS, Das M, Sreeramulu S, Sirajuddin M, Srinivasan S, Krishnamurthy V, Ranjani R, Ramakrishnan C, Varadarajan R.
    Proteins; 2007 Feb 01; 66(2):480-91. PubMed ID: 17034035
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.